Translating business research to practice: bridging the gap for real-world impact
Thomas G. Pittz
doaj +1 more source
Enhancing the pricing efficiency of financial assets with an optimized bayesian network based on efficient fusion. [PDF]
Fu Q, Li X.
europepmc +1 more source
Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova +5 more
wiley +1 more source
BRI DataLab: an AI-assisted research platform for Chinese infrastructure finance. [PDF]
Koshy SS.
europepmc +1 more source
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang +6 more
wiley +1 more source
Retraction Note: COVID-19 Crisis Impact on the Stability Between Parties in Crowdfunding and Crowdsourcing. [PDF]
Liu ZJ +3 more
europepmc +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
Innovative financial mechanisms and investments to drive change in the global beef sector. [PDF]
Talbott C +4 more
europepmc +1 more source
Economic evaluations of antiobesity medications: A systematic literature review
The global prevalence of obesity is rising rapidly. With several antiobesity medications approved and many more in development, understanding their economic value is increasingly important. This study reviews full economic evaluations of approved antiobesity medications to assess cost‐effectiveness and inform reimbursement and access decisions.
Martina Jurković +5 more
wiley +1 more source
From "Supplementing Points" to "Strengthening Network": The triple logic of new quality productivity empowering green and low-carbon manufacturing. [PDF]
Liang S, Jiang H, Wang P, Zhang M.
europepmc +1 more source

